Zhejiang Huakang Pharmaceutical Co Ltd (605077) - Total Liabilities

Latest as of June 2025: CN¥4.32 Billion CNY ≈ $632.34 Million USD

Based on the latest financial reports, Zhejiang Huakang Pharmaceutical Co Ltd (605077) has total liabilities worth CN¥4.32 Billion CNY (≈ $632.34 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see Zhejiang Huakang Pharmaceutical Co Ltd asset portfolio.

Zhejiang Huakang Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Zhejiang Huakang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Zhejiang Huakang Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Zhejiang Huakang Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang Huakang Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Regal Partners Ltd AU:RPL	Australia	AU$164.10 Million
Neuropace Inc NASDAQ:NPCE	USA	$84.44 Million
Shanghai Kindly Entrp Dvlp Grp SHG:603987	China	CN¥1.19 Billion
Genbyte Technology Inc SHE:003028	China	CN¥981.62 Million
MapLight Therapeutics, Inc. Common Stock NASDAQ:MPLT	USA	$21.14 Million
Shandong Donghong Pipe Ind Co SHG:603856	China	CN¥929.28 Million
Jereissati Participações S.A. SA:IGTI3	Brazil	R$5.13 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Zhejiang Huakang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check asset resilience ratio of Zhejiang Huakang Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.65	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.57	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Huakang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Zhejiang Huakang Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.74 Billion ≈ $546.80 Million	+21.45%
2023-12-31	CN¥3.08 Billion ≈ $450.21 Million	+146.29%
2022-12-31	CN¥1.25 Billion ≈ $182.80 Million	+119.33%
2021-12-31	CN¥569.56 Million ≈ $83.34 Million	+16.20%
2020-12-31	CN¥490.16 Million ≈ $71.73 Million	+4.47%
2019-12-31	CN¥469.20 Million ≈ $68.66 Million	-22.73%
2018-12-31	CN¥607.22 Million ≈ $88.86 Million	+18.10%
2017-12-31	CN¥514.17 Million ≈ $75.24 Million	-5.83%
2016-12-31	CN¥546.03 Million ≈ $79.90 Million	--

About Zhejiang Huakang Pharmaceutical Co Ltd

SHG:605077 China Chemicals

Market Cap

$478.05 Million

CN¥3.27 Billion CNY

Market Cap Rank

#12555 Global

#3646 in China

Share Price

CN¥10.78

Change (1 day)

-2.27%

52-Week Range

CN¥10.04 - CN¥19.78

All Time High

CN¥42.31